Revision of USP Chapter <541> Titrimetry
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
In the Pharmacopeial Forum, PF 48(5), a revision of USP chapter <541> Titrimetry is being proposed. The proposal is based on the version of the chapter official prior to 2013.
The chapter was previously divided into the following main sections:
- Direct titrations
- Residual titrations
- Complexometric titrations
- Oxidation-reduction (Redox) titrations
- Titrations in nonaqueros solvents
- Indicator and potentiometric endpoint detection
- Blank corrections
- Introduction
- Types of titrations
- Materials and equipment
In addition, besides minor editorial changes, the following updates are mentioned in the briefing notes:
- "Incorporate most of the currently official chapter information into the revised chapter in corresponding sections with the same section titles, if applicable.
- Replace Table 1 and Table 2 with information provided under Types of Titrations and Materials and Equipment.
- Add Automated Titration and Standardization of Titrants to provide current information regarding modern titrimetry processes."
The draft of the revised chapter is available on PF Online. Comments can be submitted until November 30, 2022.
Related GMP News
08.07.2026Revised Annex 19 on Reference and Retention Samples
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem


